Feb

    Do "Fixes" Fix Anything? Panel on Antitrust Remedies

    5:30 PM EST

    The adequacy of remedies in mergers and other antitrust matters has stirred a fair amount of debate.  The work of John Kwoka has raised questions about whether partial divestitures or behavioral remedies have prevented supracompetitive prices post-merger, while the Federal Trade Commission's study of merger remedies found they were largely effective at maintaining competition.  Assistant Attorney General Delrahim has indicated skepticism for behavioral remedies, and questions remain about partial divestitures.  Three leading experts on antitrust remedies will present different points of view on the effectiveness of the antitrust agencies’ remedies and what the agencies should do going forward.

    In-Person and Via-Telephone
    Navigant Economics
    1200 19th St. NW
    Suite 700
    Washington, DC 20036

    5:30 p.m.ET: Panel discussion begins
    6:30 p.m.ET: Refreshments and networking 

    FREE:  Antitrust Section Members, Government, Non-profit Employees, Students.
    $25 Other Non-Members

    Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25.   For this and all upcoming events visit http://ambar.org/atevents.
     
    CLE
    The ABA is not seeking CLE credit for this program.

    Audio Archive:  Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

    $25
    NON-MEMBERS
    $10
    MEMBERS
    $0
    SECTION MEMBERS
    Register Now *Additional discounts may apply at checkout

    Log In to view your rate

    Do "Fixes" Fix Anything? Panel on Antitrust Remedies

    Event Details

    Format

    Teleconference

    Date

    Feb 13, 2018

    2018-02-13T17:30:00-05:00 2018-02-13T18:30:00-05:00 Do "Fixes" Fix Anything? Panel on Antitrust Remedies

    The adequacy of remedies in mergers and other antitrust matters has stirred a fair amount of debate.  The work of John Kwoka has raised questions about whether partial divestitures or behavioral remedies have prevented supracompetitive prices post-merger, while the Federal Trade Commission's study of merger remedies found they were largely effective at maintaining competition.  Assistant Attorney General Delrahim has indicated skepticism for behavioral remedies, and questions remain about partial divestitures.  Three leading experts on antitrust remedies will present different points of view on the effectiveness of the antitrust agencies’ remedies and what the agencies should do going forward.

    In-Person and Via-Telephone
    Navigant Economics
    1200 19th St. NW
    Suite 700
    Washington, DC 20036

    5:30 p.m.ET: Panel discussion begins
    6:30 p.m.ET: Refreshments and networking 

    FREE:  Antitrust Section Members, Government, Non-profit Employees, Students.
    $25 Other Non-Members

    Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25.   For this and all upcoming events visit http://ambar.org/atevents.
     
    CLE
    The ABA is not seeking CLE credit for this program.

    Audio Archive:  Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

    Speakers

    Deborah Feinstein

    Arnold & Porter Kaye Scholer LLP

    Diana Moss

    American Antitrust Institute

    Sponsors

    Economics

    Section of Antitrust Law

    Co-sponsors

    Federal Civil Enforcement

    Mergers and Acquisitions

    Moderators

    Related Products

    Related On-Demand CLE